This program is intended for healthcare professionals outside the United States only.

Odevixibat adult PFIC promise and US prevalence of cholestatic gene variants in ICP

Dr. Tatyana Kushner discusses real-world outcomes with odevixibat in adult-onset PFIC and highlights new insights into cholestatic gene mutation prevalence in a diverse US population with intrahepatic cholestasis of pregnancy. 

This video offers subtitles in English, French, Portuguese, and Spanish, which can be enabled using the subtitle icon  in the video player.

Enjoyed this? You might like: